Encompass Health Corp (EHC)

Return on equity (ROE)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 455,700 422,400 399,500 376,800 352,000 353,800 354,000 333,900 333,300 335,500 350,000 391,500 411,200 405,300 382,700 303,400 283,300 265,000 284,800 342,500
Total stockholders’ equity US$ in thousands 2,792,700 1,959,800 1,839,400 1,741,900 1,647,500 1,560,400 1,475,300 1,383,500 1,310,300 1,217,000 2,003,000 1,973,500 1,911,300 1,842,700 1,762,000 1,655,100 1,588,000 1,520,800 1,462,800 1,443,900
ROE 16.32% 21.55% 21.72% 21.63% 21.37% 22.67% 24.00% 24.13% 25.44% 27.57% 17.47% 19.84% 21.51% 21.99% 21.72% 18.33% 17.84% 17.43% 19.47% 23.72%

December 31, 2024 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $455,700K ÷ $2,792,700K
= 16.32%

Encompass Health Corp's return on equity (ROE) has shown some fluctuations over the past few years.

The ROE was relatively stable at around 17-18% during the latter half of 2020 and the first quarter of 2021. It then experienced an increase, reaching a peak of 27.57% in the third quarter of 2022, indicating improved efficiency in generating profits from shareholders' equity.

However, the ROE started to decline gradually after the third quarter of 2022, dropping to 16.32% by the end of 2024. This decrease could be attributed to various factors such as changes in profitability, leverage, or equity levels.

Overall, Encompass Health Corp's ROE performance has exhibited both growth and decline during the period under review, highlighting the importance of continuous monitoring and analysis to understand the underlying drivers of these fluctuations.


Peer comparison

Dec 31, 2024

Company name
Symbol
ROE
Encompass Health Corp
EHC
16.32%
Mednax Inc
MD
-12.95%
Select Medical Holdings
SEM
10.77%